MARKET

RMD

RMD

Resmed
NYSE

Real-time Quotes | Nasdaq Last Sale

194.22
-4.24
-2.14%
Opening 10:57 05/24 EDT
OPEN
195.42
PREV CLOSE
198.46
HIGH
196.61
LOW
192.86
VOLUME
109.47K
TURNOVER
11.13M
52 WEEK HIGH
301.34
52 WEEK LOW
189.40
MARKET CAP
28.41B
P/E (TTM)
36.60
1D
5D
1M
3M
1Y
5Y
Could The Market Be Wrong About ResMed Inc. (NYSE:RMD) Given Its Attractive Financial Prospects?
With its stock down 19% over the past month, it is easy to disregard ResMed (NYSE:RMD). But if you pay close attention...
Simply Wall St. · 3d ago
Even 2 Hours of PAP Therapy per Night Benefits Sleep Apnea Sufferers: ResMed Study
2–3 hours of nightly PAP use shows health benefits at 3 months, 1 year, and 2 yearsHealth benefits significantly increase by use hour/night, up to 7 hours SAN FRANCISCO, May 18, 2022 (GLOBE NEWSWIRE) -- Sleep apnea sufferers can gain health benefits from P...
GlobeNewswire · 5d ago
Insider Sell: Resmed
MT Newswires · 05/17 14:19
ResMed goes ex-dividend tomorrow
ResMed (NYSE:RMD) had declared $0.42/share quarterly dividend, in line with previous. Payable June 16; for shareholders of record May 12; ex-div May 11. See RMD Dividend Scorecard, Yield Chart, &
Seekingalpha · 05/10 18:16
Here's What We Like About ResMed's (NYSE:RMD) Upcoming Dividend
Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...
Simply Wall St. · 05/06 11:52
Insulet Reports Q1 Profit , Names New CEO
MT Newswires · 05/05 16:54
ResMed Earnings Perspective: Return On Invested Capital
Pulled from Benzinga Pro data, ResMed (NYSE:RMD) posted Q3 earnings of $179.01 million, an increase from Q2 of 11.27%. Sales dropped to $864.50 million, a 3.39% decrease between quarters.
Benzinga · 05/03 13:59
Research Alert: CFRA Keeps Sell Opinion On Shares Of Resmed Inc.
MT Newswires · 05/02 13:36
More
No Data
Learn about the latest financial forecast of RMD. Analyze the recent business situations of Resmed through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 11 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

27.27%Strong Buy
18.18%Buy
45.45%Hold
9.09%Under-perform
0.00%Sell
Analyst Price Target
The average RMD stock price target is 240.83 with a high estimate of 276.00 and a low estimate of 201.00.
High276.00
Average240.83
Low201.00
Current 194.22
EPS
Actual
Estimate
0.380.761.141.52
Q4 2021
Q1 2022
Q2 2022
Q3 2022
Q4 2022
Institutional Holdings
Institutions: 877
Institutional Holdings: 106.59M
% Owned: 72.87%
Shares Outstanding: 146.28M
TypeInstitutionsShares
Increased
215
6.81M
New
51
646.01K
Decreased
264
3.37M
Sold Out
87
1.21M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
-1.82%
Healthcare Equipment & Supplies
-1.75%
Key Executives
Non-Executive Chairman
Peter Farrell
President/Chief Operating Officer
Robert Douglas
Chief Executive Officer/Director
Michael Farrell
Chief Financial Officer
Brett Sandercock
Corporate Executive
Bobby Ghoshal
Corporate Executive
Justin Leong
Chief Technology Officer
Urvashi Tyagi
Chief Administrative Officer/General Counsel/Secretary
David Pendarvis
Lead Director/Independent Director
Ronald Taylor
Independent Director
Carol Burt
Independent Director
Jan De Witte
Independent Director
Karen Drexler
Independent Director
Harjit Gill
Independent Director
Richard Sulpizio
No Data
No Data
About RMD
ResMed Inc. is a holding company. The Company is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep apnea, chronic obstructive pulmonary disease (COPD), neuromuscular disease and other chronic diseases. The Company operates through two segments: Sleep and Respiratory Care segment, and the Software-as-a-Service (SaaS) segment. Sleep apnea includes obstructive sleep apnea and other respiratory disorders that occur during sleep. Its cloud-based digital health applications, along with its devices, are designed to provide connected care to improve patient outcomes. The Company's portfolio of products includes ventilation devices, diagnostic products, mask systems, headgear and other accessories, dental devices, portable oxygen concentrators (POCs) and cloud-based software informatics solutions.

Webull offers kinds of ResMed Inc. stock information, including NYSE:RMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RMD stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading RMD stock methods without spending real money on the virtual paper trading platform.